29 related articles for article (PubMed ID: 8615649)
1. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.
Lewis GD; Figari I; Fendly B; Wong WL; Carter P; Gorman C; Shepard HM
Cancer Immunol Immunother; 1993 Sep; 37(4):255-63. PubMed ID: 8102322
[TBL] [Abstract][Full Text] [Related]
2. Effects of tumor necrosis factor alpha, interferon alpha and interferon gamma on non-lymphoid leukemia cell lines: growth inhibition, differentiation induction and drug sensitivity modulation.
Kikuchi A; Holán V; Minowada J
Cancer Immunol Immunother; 1992; 35(4):257-63. PubMed ID: 1511460
[TBL] [Abstract][Full Text] [Related]
3. Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency.
Srinivas U; Tagliabue E; Campiglio M; Ménard S; Colnaghi MI
Cancer Immunol Immunother; 1993 Jun; 36(6):397-402. PubMed ID: 8098992
[TBL] [Abstract][Full Text] [Related]
4. Immunocytokines with activity-on-demand by combination with small molecule inhibitors.
Müller D
EMBO Mol Med; 2024 Apr; 16(4):670-671. PubMed ID: 38448542
[TBL] [Abstract][Full Text] [Related]
5. Standardization of
Mazhar M; Agrawal SS
Front Pharmacol; 2021; 12():642067. PubMed ID: 34916928
[No Abstract] [Full Text] [Related]
6. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.
Mohammad Mirzaei N; Su S; Sofia D; Hegarty M; Abdel-Rahman MH; Asadpoure A; Cebulla CM; Chang YH; Hao W; Jackson PR; Lee AV; Stover DG; Tatarova Z; Zervantonakis IK; Shahriyari L
J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683171
[TBL] [Abstract][Full Text] [Related]
7. The Study of Association Between Polymorphism of TNF-α Gene's Promoter Region and Recurrent Pregnancy Loss.
Aboutorabi R; Behzadi E; Sadegh MJ; Fatehi SP; Semsarzadeh S; Zarrin Y; Kazemi M; Rafiee L; Mostafavi FS
J Reprod Infertil; 2018; 19(4):211-218. PubMed ID: 30746336
[TBL] [Abstract][Full Text] [Related]
8.
Abd-Ellatef GF; Ahmed OM; Abdel-Reheim ES; Abdel-Hamid AZ
Breast Cancer (Dove Med Press); 2017; 9():67-83. PubMed ID: 28280387
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α gene polymorphisms in Korean patients with recurrent spontaneous abortion.
Lee BE; Jeon YJ; Shin JE; Kim JH; Choi DH; Jung YW; Shim SH; Lee WS; Kim NK
Reprod Sci; 2013 Apr; 20(4):408-13. PubMed ID: 23202728
[TBL] [Abstract][Full Text] [Related]
10. The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model.
el-Aziz MA; Hassan HA; Mohamed MH; Meki AR; Abdel-Ghaffar SK; Hussein MR
Int J Exp Pathol; 2005 Dec; 86(6):383-96. PubMed ID: 16309544
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.
McKeage K; Perry CM
Drugs; 2002; 62(1):209-43. PubMed ID: 11790161
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
Sarup JC; Johnson RM; King KL; Fendly BM; Lipari MT; Napier MA; Ullrich A; Shepard HM
Growth Regul; 1991 Jun; 1(2):72-82. PubMed ID: 1688187
[TBL] [Abstract][Full Text] [Related]
13. Control of breast tumor cell growth using a targeted cysteine protease inhibitor.
Xing R; Wu F; Mason RW
Cancer Res; 1998 Mar; 58(5):904-9. PubMed ID: 9500448
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.
Dodge GR; Diaz A; Sanz-Rodriguez C; Reginato AM; Jimenez SA
Arthritis Rheum; 1998 Feb; 41(2):274-83. PubMed ID: 9485085
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
Shepard HM; Lewis GD; Sarup JC; Fendly BM; Maneval D; Mordenti J; Figari I; Kotts CE; Palladino MA; Ullrich A
J Clin Immunol; 1991 May; 11(3):117-27. PubMed ID: 1679763
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of breast cancer cell lines by combinations of anti-P185HER2 monoclonal antibody and cytokines.
Kopreski MS; Lipton A; Harvey HA; Kumar R
Anticancer Res; 1996; 16(1):433-6. PubMed ID: 8615649
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha.
Kumar R; Mendelsohn J
Anticancer Res; 1994; 14(3A):1001-8. PubMed ID: 7915505
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
